Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outlook Therapeutics (OTLK) Times Interest Earned (2016 - 2020)

Outlook Therapeutics (OTLK) has disclosed Times Interest Earned for 6 consecutive years, with -$26.78 as the latest value for Q2 2020.

  • On a quarterly basis, Times Interest Earned fell 413.23% to -$26.78 in Q2 2020 year-over-year; TTM through Jun 2025 was -$104.41, a N/A change, with the full-year FY2024 number at -$22.71, down 8.22% from a year prior.
  • Times Interest Earned was -$26.78 for Q2 2020 at Outlook Therapeutics, down from -$9.72 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$1.18 in Q3 2017 to a low of -$73.56 in Q2 2016.
  • A 5-year average of -$16.94 and a median of -$8.28 in 2018 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: surged 94.29% in 2017, then plummeted 849.73% in 2018.
  • Outlook Therapeutics' Times Interest Earned stood at -$36.38 in 2016, then skyrocketed by 87.82% to -$4.43 in 2017, then tumbled by 106.61% to -$9.15 in 2018, then crashed by 49.63% to -$13.69 in 2019, then crashed by 95.55% to -$26.78 in 2020.
  • Per Business Quant, the three most recent readings for OTLK's Times Interest Earned are -$26.78 (Q2 2020), -$9.72 (Q1 2020), and -$13.69 (Q4 2019).